As an eye care professional, you will already know that a consequence of long-term Dry Eye Disease, MGD and blepharitis can be the loss of eyelashes and eyelash condition. This can result in patients self-confidence being impacted. All too often this is remedied by them purchasing one of the growing numbers of products found online.
What your patients may not be aware of is that their chosen product could contain ingredients which will make their dry eye condition worse. Now, at Positive Impact we have a – free from bimataprost – alternative for you to recommend.
New Lash Builder has been developed by the maker of DemEx, a leading Dry Eye optometrist, for use by other eye care professionals.
A common complaint
Living with Dry Eye can be both physically and emotionally debilitating for your patients. Increasingly, the impact on patients’ self-esteem is becoming a focus of care consideration, including the loss of eyelash condition.1,2
You may also be seeing more lash problems due to the growing trend for stick-on lashes and extensions.
How Lash Builder works
This highly innovative formulation works using a biomimetic peptide (acetyl-tetrapeptide) and red clover extract, key ingredients that impact eyelash loss and support new growth.
Expertly formulated by the makers of DemEx
Lash Builder is free from PGA based ingredients or their synthetic derivatives and harsh preservatives including BAK to avoid dry eye symptoms increasing
Works while your patients sleep
Improvements are seen after just 5-6 weeks. Patients apply Lash Builder nightly to their clean eyelids before bed. Do not rinse off, Lash Builder works overnight. Rinse off as part of the usual morning care routine.
References:
1. Mertzanis P, Venkataraman K, Begley C, Chalmers R, Abetz L. The Impact of Dry Eye on Daily Life: Results from a Qualitative Study. Investigative Ophthalmology & Visual Science December 2002, Vol.43, 74.
2. Kitazawa M, Sakamoto C, Yoshimura M, Kawashima M, Inoue S, Mimura M, Tsubota K, Negishi K, Kishimoto T. The Relationship of Dry Eye Disease with Depression and Anxiety: A Naturalistic Observational Study. Transl Vis Sci Technol. 2018 Dec 28;7(6):35. doi: 10.1167/tvst.7.6.35. PMID: 30619655; PMCID: PMC6314109.